Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Yan Trokel, MD, Cosmetic Surgeon, Founder and Director The YAN Center for Corrective & Cosmetic Surgery, discusses body contouring using the “Zerona” device, a procedure not recommended for…
Donnica Moore, MD, President, Sapphire Women’s Health Group, discusses Chronic Fatigue Syndrome and what it is not. She describes in detail how to differentiate CFS from depression, fatigue…
NEW YORK (Reuters Health) – For patients presenting to the emergency department (ED) with migraine, IV prochlorperazine with diphenhydramine is more effective than subcutaneous sumatriptan, a small prospective…
NEW YORK (Reuters Health) – The incidence of acute kidney injury after transcatheter aortic valve implantation (TAVI) is higher than 10%, a Canadian study shows. As reported in…
NEW YORK (Reuters Health) – All cesarean sections put women at increased risk of adverse events, including death, according to the World Health Organization’s Global Survey on Maternal…
NEW YORK (Reuters Health) – Just like cocaine and other drugs that increase brain dopamine levels, the dopamine agonists used to treat Parkinson disease can also produce a…
NEW YORK (Reuters Health) – Patients with non-ST-segment elevation acute coronary syndrome and elevated troponin T get no long term benefits from early invasive treatment as opposed to…
NEW YORK (Reuters Health) – Active tuberculosis is more readily found with commercially available interferon-gamma release assays than with tuberculin skin tests, according to a meta-analysis. Furthermore, when…
NEW YORK (Reuters Health) – Ventilator-associated pneumonia is less likely to be fatal when patients are intubated with a silver-coated endotracheal tube, according to a post hoc analysis…
NEW YORK (Reuters Health) – Magnetic guidewire navigation is feasible in primary percutaneous coronary intervention (PCI), according to results of a noninferiority trial performed in the Netherlands. Moreover,…
